concluded PD-L1 mRNA expression is comparable to PD-L1 protein expression by immunohistochemistry (IHC) both analytically and clinically in predicting ICI response rates in NSCLC [11]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.